NR6A1 and neoplasm of testis: In summary, our findings reveal a novel regulatory pathway of miR‐196a‐5p/NR6A1/E‐cadherin in inhibiting the proliferation, migration, invasion, and neurogenesis of testicular tumor cell in vivo and in vitro, which provides a potential biomarker for targeted TGCTs therapy.